The pattern that warrants deeper investigation is this: multiple body systems are affected, conventional labs have returned normal, standard treatments havent produced lasting improvement, and symptoms may worsen in specific environments (home, office, or car) and improve when youre away
Likely related to changing definitions of IC, reported prevalence rates varied substantially among early population-based studies, ranging widely from 18 to 865 women per 100,000 (0.02%0.9% prevalence
Commenting on the patient safety alert, Douglas Twenefour, head of care at Diabetes UK, said: The ongoing shortages of GLP-1 medications are having serious implications for many people with T2DM and are still a major concern
Medically reviewed by Dr Sultan Linjawi, Endocrinologist & Diabetes Specialist January 2026 Subscribe to Receive One of Our Helpful Free Guides Click the guide that would be the most useful What is Rybelsus (oral Semaglutide)
Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy